業績紹介

2013年 論文

  • What is the most effective tool for detecting prostate cancer using a standard MR scanner?
    Osugi K, Tanimoto A, Nakashima J, Shinoda K, Hashiguchi A, Oya M, Jinzaki M, Kuribayashi S.
    Magn Reson Med Sci. 2013 Dec 25;12(4):271-80. Epub 2013 Oct 29.
  • Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
    Ide H, Kikuchi E, Hasegawa M, Hattori S, Yasumizu Y, Miyajima A, Oya M.
    Cancer Med. 2013 Aug;2(4):488-95.
  • Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy.
    Hasegawa M, Miyajima A, Jinzaki M, Maeda T, Takeda T, Kikuchi E, Shibata H, Oya M.
    Urology. 2013 Dec;82(6):1312-8.
  • Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells.
    Suzuki K, Mizuno R, Suenaga K, Teruya T, Tanaka N, Kosaka T, Oya M.
    Cancer Med. 2013 Feb;2(1):32-9.
  • Three cases of IgG4-related disease associated with urinary tract obstruction].
    Yazawa S, Ohara R, Maeda T, Kanao K, Hattori S, Nakajima Y, Oya M.
    Nihon Hinyokika Gakkai Zasshi. 2013 Jul;104(4):620-5. Japanese.
  • Effect of a novel nuclear factor-κB activation inhibitor on renal ischemia-reperfusion injury.
    Kono H, Nakagawa K, Morita S, Shinoda K, Mizuno R, Kikuchi E, Miyajima A, Umezawa K, Oya M.
    Transplantation. 2013 Nov 27;96(10):863-70.
  • Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Shirotake S, Hayakawa N, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Oya M.
    BJU Int. 2013 Jul;112(2):E28-34.
  • Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming.
    Kosaka T, Nagamatsu G, Saito S, Oya M, Suda T, Horimoto K.
    Cancer Sci. 2013 Aug;104(8):1017-26.
  • Epithelioid angiomyolipoma of the kidney: radiological imaging.
    Tsukada J, Jinzaki M, Yao M, Nagashima Y, Mikami S, Yashiro H, Nozaki M, Mizuno R, Oya M, Kuribayashi S.
    Int J Urol. 2013 Nov;20(11):1105-11.
  • [The molecular mechanisms of resistance to androgen deprivation therapy in prostate cancer].
    Kosaka T, Oya M.
    Nihon Rinsho. 2012 Nov;70 Suppl 8:353-9. Japanese. No abstract available.
  • Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.
    Kosaka T, Miyajima A, Nagata H, Maeda T, Kikuchi E, Oya M.
    Sci Rep. 2013;3:1268.
  • Radiolucent circular line in pelvis on plain x-rays.
    Niwa N, Yazawa S, Oya M.
    J Emerg Med. 2013 Dec;45(6):e225-6. doi: 10.1016/j.jemermed.2013.08.050. Epub 2013 Oct 7. No abstract available.
  • Technical difficulties of transumbilical laparoendoscopic single-site adrenalectomy: comparison with conventional laparoscopic adrenalectomy.
    Ishida M, Miyajima A, Takeda T, Hasegawa M, Kikuchi E, Oya M.
    World J Urol. 2013 Feb;31(1):199-203.
  • Periprostatic fat area is an independent factor that prolonged operative time in laparoscopic radical prostatectomy.
    Kaneko G, Miyajima A, Yuge K, Hasegawa M, Takeda T, Jinzaki M, Kikuchi E, Nakagawa K, Oya M.
    Urology. 2013 Dec;82(6):1304-9.
  • Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.
    BJU Int. 2013 May;111(6):857-64.
  • Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hagiwara M, Kikuchi E, Tanaka N, Matsumoto K, Ide H, Miyajima A, Masuda T, Nakamura S, Oya M.
    J Urol. 2013 Jun;189(6):2062-8.
  • Induction of pluripotent stem cells from primordial germ cells by single reprogramming factors.
    Nagamatsu G, Kosaka T, Saito S, Honda H, Takubo K, Kinoshita T, Akiyama H, Sudo T, Horimoto K, Oya M, Suda T.
    Stem Cells. 2013 Mar;31(3):479-87.
  • C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol. 2013 Nov;31(8):1725-30.
  • Burden of overactive bladder symptom on quality of life in stroke patients.
    Itoh Y, Yamada S, Konoeda F, Koizumi K, Nagata H, Oya M, Suzuki N.
    Neurourol Urodyn. 2013 Jun;32(5):428-34.
  • Does laparoendoscopic single-site adrenalectomy increase surgical risk in patients with pheochromocytoma?
    Hattori S, Miyajima A, Maeda T, Hasegawa M, Takeda T, Kosaka T, Kikuchi E, Nakagawa K, Oya M.
    Surg Endosc. 2013 Feb;27(2):593-8.
  • What is the predictor of prolonged operative time during laparoscopic radical prostatectomy?
    Kaneko G, Miyajima A, Yazawa S, Yuge K, Kikuchi E, Asanuma H, Nakagawa K, Oya M.
    Int J Urol. 2013 Mar;20(3):330-6.
  • How can lymphocele development be prevented after laparoscopic radical prostatectomy?
    Yasumizu Y, Miyajima A, Maeda T, Takeda T, Hasegawa M, Kosaka T, Kikuchi E, Oya M.
    J Endourol. 2013 Apr;27(4):447-51.
  • A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol. 2013 Mar;189(3):1014-8.
業績紹介